Pasithea Therapeutics Corp.
↗Miami Beach, USA
Pasithea Therapeutics is a clinical-stage biotechnology company focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) disorders, RASopathies, and cancers. The company leverages expertise in neuroscience, translational medicine, and drug development to advance a portfolio of proprietary drug candidates.
Its lead product candidate, PAS-004, is a next-generation macrocyclic MEK inhibitor designed to address limitations of existing therapies in treating RASopathies (such as Neurofibromatosis type 1) and various MAPK pathway-driven tumors. The company is actively conducting clinical trials for PAS-004 in the United States, Australia, and South Korea.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2020
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
STOCK
Exchange:NASDAQ
Ticker:KTTA
Market Cap:$0.017B
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1/1b
Modalities:Small molecule
Active Trials:2
Trial Phases:Phase 1: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Pasithea MacroMEK Pty Ltd
Key Partnerships:Novotech (Clinical Research Organization)
COMPETITION
Position:Emerging
Competitors:Alexion Pharmaceuticals (AstraZeneca)
LEADERSHIP
Key Executives:
Tiago Reis Marques - CEO
Lawrence J. Steinman - Co-Founder
Scientific Founders:Yassine Bendiabdallah, Lawrence J. Steinman
LINKS
Website:pasithea.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Pasithea Therapeutics Corp. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Pasithea Therapeutics Corp.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.